[PDF][PDF] Customized oligonucleotide microarray gene expression–based classification of neuroblastoma patients outperforms current clinical risk stratification
A Oberthuer, F Berthold, P Warnat, B Hero… - Journal of clinical …, 2006 - academia.edu
A Oberthuer, F Berthold, P Warnat, B Hero, Y Kahlert, R Spitz, K Ernestus, R König, S Haas…
Journal of clinical oncology, 2006•academia.eduCustomized Oligonucleotide Microarray Gene Expression– Based Classification of
Neuroblastoma Patients Outperforms Current Clin Page 1 Customized Oligonucleotide Microarray
Gene Expression– Based Classification of Neuroblastoma Patients Outperforms Current Clinical
Risk Stratification André Oberthuer, Frank Berthold, Patrick Warnat, Barbara Hero, Yvonne
Kahlert, Rüdiger Spitz, Karen Ernestus, Rainer König, Stefan Haas, Roland Eils, Manfred
Schwab, Benedikt Brors, Frank Westermann, and Matthias Fischer A B S T R A C T Purpose To …
Neuroblastoma Patients Outperforms Current Clin Page 1 Customized Oligonucleotide Microarray
Gene Expression– Based Classification of Neuroblastoma Patients Outperforms Current Clinical
Risk Stratification André Oberthuer, Frank Berthold, Patrick Warnat, Barbara Hero, Yvonne
Kahlert, Rüdiger Spitz, Karen Ernestus, Rainer König, Stefan Haas, Roland Eils, Manfred
Schwab, Benedikt Brors, Frank Westermann, and Matthias Fischer A B S T R A C T Purpose To …
Purpose
To develop a gene expression–based classifier for neuroblastoma patients that reliably predicts courses of the disease.
academia.edu